Phathom Pharmaceuticals, Inc. PHAT Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $180.9M-14.8% | $129.97M-56.3% | $135.16M-59.6% | $149.57M-45.9% | $212.32M-34.1% | ||
| $265.9M+148% | $221.54M+197% | $182.21M+387% | $147.47M+800% | $107.09M+1,841% | ||
| $88.58M+84.9% | $92.52M+178% | $83.33M+178% | $65.41M+173% | $47.9M+184% | ||
| $276.57M+4.4% | $228.97M-36.4% | $207.78M-44.4% | $218.88M-28.2% | $264.9M-22.2% | ||
| $1.02M-25.0% | $1.06M-27.9% | $1.16M-30.2% | $1.24M-31.5% | $1.35M-31.0% | ||
| $305.12M+3.7% | $259.15M-31.5% | $240.29M-37.9% | $250.22M-21.7% | $294.21M-17.5% | ||
| $6.37M-45.2% | $4.98M-52.6% | $1.08M-84.9% | $4.01M-47.6% | $11.62M+38.2% | ||
| $33.02M+91.2% | $27.25M+37.8% | $24.34M+20.6% | $21.53M+117% | $17.27M+4.8% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $125.04M+68.9% | $132.04M+54.0% | $93.12M+42.6% | $91.82M+95.3% | $74.03M+70.3% | ||
| $163.68M-19.5% | $209.09M+3.8% | $207.09M+17.8% | $205.14M+17.6% | $203.25M+36.4% | ||
| $642.08M+1.5% | $697.32M+10.4% | $662.82M+15.4% | $656.05M+18.6% | $632.58M+25.3% | ||
| $7K+16.7% | $6K0.0% | $6K0.0% | $6K+20.0% | $6K+20.0% | ||
| -$1.51B-11.6% | -$1.48B-17.5% | -$1.46B-23.1% | -$1.43B-29.9% | -$1.36B-34.2% | ||
| -$336.96M+0.4% | -$438.17M-72.8% | -$422.53M-126% | -$405.83M-73.6% | -$338.38M-128% | ||
| $305.12M+3.7% | $259.15M-31.5% | $240.29M-37.9% | $250.22M-21.7% | $294.21M-17.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Phathom Pharmaceuticals, Inc.'s total assets?
- Phathom Pharmaceuticals, Inc. (PHAT) holds $305.1M in total assets, up 3.7% year over year.
- How much debt does Phathom Pharmaceuticals, Inc. have?
- Phathom Pharmaceuticals, Inc. carries $166.3M in total debt against -$337.0M of shareholders' equity, a debt-to-equity ratio of 5.64.
- How much cash does Phathom Pharmaceuticals, Inc. have?
- Phathom Pharmaceuticals, Inc. holds $180.9M in cash and equivalents.
- Can Phathom Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 2.21 — current assets exceed current liabilities.
- Where does Phathom Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Phathom Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
